Skip to main content

Click here for updates and notices regarding Nova Scotia Health and COVID-19

Policies, Procedures, and Guidelines

News and Updates RSS  

Privacy legislation and research

Research in Nova Scotia must comply with both the Personal Information International Disclosure Act (PIIDPA) and the Personal Health Information Act (PHIA).

PIIDPA

The Personal Information International Disclosure Protection Act (PIIDPA) came into effect in 2006. It protects privacy by restricting the disclosure of personal information outside Canada, as other countries may not have equivalent data protection laws. Personal information (including participants’ personal health information and researchers’ CVs) may be stored or accessed outside Canada only with the consent of the individual.

PHIA

The Personal Health Information Act (PHIA) came into force on June 1, 2013. This legislation, similar to that in existence in other provinces, deals with the collection, use, disclosure, retention, disposal, and destruction of personal health information. PHIA introduces new requirements for research in Nova Scotia, which has led to modifications to many procedures, practices and forms at the Nova Scotia Health Authority.

Video

Personal Health Information Act and Research

Quality resources

Research Standards and Regulations

Health Canada

Inter-agency Advisory Panel on Research Ethics

International

United States

Resource Documents and Tools

  • Supports for Investigator-Sponsored Clinical Trials

Institutional Accreditation Certificates

Standard Operating Procedures and Guidelines

The Research Quality Program is pleased to introduce and release several institutional Standard Operating Procedures (SOPs) for Health Canada regulated clinical trials. The goal of these SOPs is to provide consistency and efficiency for research groups. 

We recognize that many groups have created existing departmental SOPs. Research teams are not required to replace their current SOPs with institutional SOPs provided their current SOPs contain the components as described in the attached institutional SOPs. Our aim is to create SOPs that are required for ICH-GCP compliance within Health Canada regulated clinical trials and also to align REB and institutional requirements.

Non-regulated clinical trials are encouraged, but not required, to have SOPs in place. These trials must be able to show, in the Ethics Application Form for REB submission, that their consenting and privacy practices align with TCPS and privacy legislation. Feel free to adopt any of the Health Canada institutional SOPs or use them as a guide for completing appropriate sections in the EAF for REB submission.